Ranked by IMS Health as one of the fastest-growing global pharmaceutical companies worldwide in recent years, we are seeking to further expand our market share by introducing new products and maximizing sales.

Novartis Vaccines and Diagnostics, created in 2006 following the acquisition of Chiron, comprises two businesses: Novartis Vaccines and a diagnostics business that retains the Chiron name

Sandoz is a leading global supplier of generic pharmaceuticals that develops, produces and markets these drugs along with pharmaceutical and biotechnological active substances.

Novartis Consumer Health focuses on creating, developing and manufacturing a wide range of competitively differentiated products that restore, maintain or improve the health and well-being of customers.